Evidence map›Paper›PMID 39401315›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Effects of Respiratory Isolation for Tuberculosis to Reduce Community-based Transmission: A Systematic Review.

Ruvandhi R Nathavitharana, Abarna Pearl, Amanda Biewer, Laura Young, Leonard Mukasa, Naveed Delrooz, Advaith Subramanian, Sarah Miller, Sundari Mase, Sonal S Munsiff and 1 more

Abstract readSystematic Review
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Community-Based Tuberculosis Isolation Decisions Require Individualization Based on Effectiveness and Duration of Treatment, Community Risks, and Patient Harms.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruvandhi R NathavitharanaDivision of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-3544-5021
Abarna PearlDivision of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Amanda BiewerDivision of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Laura YoungVirginia Department of Health, Virginia, USA.
Leonard MukasaArkansas Department of Health, Little Rock, Arkansas, USA.
Naveed DelroozTulane University, New Orleans, Louisiana, USA.
Advaith SubramanianTulane University, New Orleans, Louisiana, USA.
Sarah MillerTulane University, New Orleans, Louisiana, USA.
Sundari MaseStop TB, Washington, District of Columbia, USA.
Sonal S MunsiffDivision of Infectious Diseases, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Edward NardellDivision of Global Health Equity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Funding

THWART-TB : Testing Health Workers At Risk to advance our understanding of TB infectionDP2AI176896 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Ruvandhi Nathavitharana · 2023 to 2026
$1.6M
Optimizing Diagnostic Strategies for TB Transmission Control in Health-Care FacilitiesK23AI132648 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NATHAVITHARANA, RUVANDHI · 2018 to 2022
$945k
NIAID NIH HHS DP2 AI176896NIAID NIH HHS K23 AI132648NIH Director's New Innovator Award NIAID DP2-AI176896NIH HHS NIAID K23 AI132648-06
6 · The paper itself

Abstract

backgroundRespiratory isolation of people with pulmonary tuberculosis (TB), including after treatment initiation, is used to prevent community-based transmission; yet guidelines on duration are limited and implementation is heterogeneous. This systematic review synthesized evidence on respiratory isolation for TB to inform National TB Coalition of America guidelines.

methodsAfter searching 6 databases, 8 reviewers screened and extracted data in duplicate on effects of respiratory isolation compared to no isolation or masking. Studies were stratified by outcomes: TB infection or disease in contacts, mortality, hospitalization duration, patient and health system costs, and impact on mental health or stigma. We used a convergent integrated approach to synthesize quantitative and qualitative findings and assess limitations.

resultsSeventeen studies were included. There were limited data directly comparing isolation to non-isolation interventions, including effects after treatment initiation. One randomized controlled trial suggested treatment in a sanatorium versus at home did not affect TB incidence in contacts. Modeling studies suggest isolation may reduce transmission but relied on various assumptions, and isolation was implemented alongside other interventions. Descriptive, mixed-methods, and qualitative studies described adverse impacts of isolation on employment, education, food/housing security, and mental health due to transmission fears, stigma, and social isolation. Impacts were compounded in marginalized groups including Indigenous and incarcerated persons.

conclusionsData to support current isolation practices, particularly after effective treatment initiation, to reduce TB transmission in communities are limited. Public health guidance should weigh the negative impacts on people with TB against decreased community transmission to make evidence-based decisions about respiratory isolation.

Indexed as

Community-Acquired InfectionsPatient IsolationTuberculosis, PulmonaryHumansisolationpublic healthpulmonary tuberculosisrespiratory isolationtuberculosis

Identifiers

PMID39401315
PMCPMC11797387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.